Pediatrix Medical Group, Inc. (NYSE:MD) Shares Bought by Performa Ltd US LLC

Performa Ltd US LLC raised its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 130.8% during the 4th quarter, Holdings Channel reports. The firm owned 3,000 shares of the company’s stock after acquiring an additional 1,700 shares during the quarter. Pediatrix Medical Group comprises about 0.0% of Performa Ltd US LLC’s holdings, making the stock its 25th biggest position. Performa Ltd US LLC’s holdings in Pediatrix Medical Group were worth $28,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Charles Schwab Investment Management Inc. lifted its position in shares of Pediatrix Medical Group by 10.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,634,065 shares of the company’s stock valued at $15,197,000 after acquiring an additional 148,600 shares in the last quarter. LSV Asset Management increased its stake in Pediatrix Medical Group by 108.9% during the fourth quarter. LSV Asset Management now owns 49,500 shares of the company’s stock worth $460,000 after acquiring an additional 25,800 shares during the last quarter. M&T Bank Corp increased its stake in Pediatrix Medical Group by 6.9% during the fourth quarter. M&T Bank Corp now owns 48,771 shares of the company’s stock worth $453,000 after acquiring an additional 3,157 shares during the last quarter. Victory Capital Management Inc. increased its stake in Pediatrix Medical Group by 191.9% during the fourth quarter. Victory Capital Management Inc. now owns 118,131 shares of the company’s stock worth $1,099,000 after acquiring an additional 77,658 shares during the last quarter. Finally, SummerHaven Investment Management LLC increased its stake in Pediatrix Medical Group by 2.3% during the fourth quarter. SummerHaven Investment Management LLC now owns 52,900 shares of the company’s stock worth $492,000 after acquiring an additional 1,208 shares during the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on MD. Jefferies Financial Group lowered their target price on Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, March 6th. TheStreet lowered Pediatrix Medical Group from a “c” rating to a “d” rating in a research note on Friday, February 23rd. Mizuho lowered their price objective on Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a research note on Wednesday, February 21st. Finally, Truist Financial lowered their price objective on Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating for the company in a research note on Wednesday, February 21st. Five research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $9.38.

Pediatrix Medical Group Stock Performance

NYSE:MD traded down $0.16 during trading hours on Thursday, reaching $8.34. 55,028 shares of the stock were exchanged, compared to its average volume of 687,982. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.73. The firm has a 50 day simple moving average of $9.23 and a 200-day simple moving average of $9.39. Pediatrix Medical Group, Inc. has a 52 week low of $7.70 and a 52 week high of $15.02. The stock has a market capitalization of $700.78 million, a P/E ratio of -11.65, a P/E/G ratio of 2.52 and a beta of 1.58.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Tuesday, February 20th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.30 by $0.02. The firm had revenue of $496.44 million for the quarter, compared to the consensus estimate of $524.30 million. Pediatrix Medical Group had a positive return on equity of 10.35% and a negative net margin of 3.03%. The firm’s revenue for the quarter was down 3.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.46 EPS. As a group, sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.12 earnings per share for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.